The University of Chicago Header Logo

Connection

Tao Xie to Patient Safety

Back to Details
This is a "connection" page, showing publications Tao Xie has written about Patient Safety.
Tao Xie
Connection Strength
0.034
Patient Safety
  1. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. Lancet Neurol. 2019 06; 18(6):549-558.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.